Interv Cardiol. 2013;5(1):93-100. In-stent thrombosis More often seen when ≥1 stent used, long stented segments of coronary artery, drug-eluting stents, bifurcation lesion stenting Incomplete ...

A one-month course of dual clot-preventing therapy followed by a single clot-prevention medication for the remainder of the ...

A bioadaptor implant that actively adapts to vessel physiology was linked to lower target lesion failure and target vessel ...

A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis ...

Results of the SMART-CASE Trial Presented at TCT 2013 SAN FRANCISCO, CA– A new study shows that a conservative approach to revascularization for patients with intermediate coronary lesions determined ...

InterVene’s Recana is claimed to be the first fully integrated catheter system to address venous in-stent restenosis (ISR).

"TCT 2025: Elixir Medical’s arterial implant drops coronary events by nearly 50%" was originally created and published by ...

A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis ...

In the treatment of larger narrowed blood vessels, drug-coated balloon catheters have been shown to deliver lasting and ...

Patients who require noncardiac surgery after receiving stents have lower rates of acute MI and/or coronary revascularization when the surgery is delayed at least 6 months, according to a study ...

There has been a tremendous growth in percutaneous coronary interventions (PCIs) with stent implantation, even in cases where coronary artery bypass grafting (CABG) demonstrates superior long-term ...